Tempus’ Solid Tumor CDx Test Gets Breakthrough Device Designation
The U.S. FDA has granted Tempus Breakthrough Device Designation for its HLA-LOH assay as a companion diagnostic (CDx) test for solid tumors.
Read More
Search Results for: lung cancer
Why Long-Term Smokers May Have a Disease that Defies Diagnosis
Millions of Americans with tobacco-related lung disease have symptoms that do not fit any existing tobacco-related disease criteria.
Read More
What MDS Misdiagnoses Trends Tells Us About Blood Cancer Diagnostics
Blood disorders known as MDS are difficult to diagnose putting patients at increased risk for treatment mistakes from misdiagnosis.
Read More
Predicting Early Cancers with Molecular Vibrations in Serum
A team of scientists developed a label-free SERS-Artificial intelligence method for cancer screening (SERS-AICS).
Read More
Novel ML Blood Test Detects Cancers with Genome-Wide Mutations in cfDNA Molecules
New blood testing tech combines genome-wide sequencing of single molecules of DNA shed from tumors and machine learning.
Read More